These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23922130)

  • 1. The Addenbrooke's Cognitive Examination-Revised accurately detects cognitive decline in Huntington's disease.
    Begeti F; Tan AY; Cummins GA; Collins LM; Guzman NV; Mason SL; Barker RA
    J Neurol; 2013 Nov; 260(11):2777-85. PubMed ID: 23922130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for specific cognitive deficits in preclinical Huntington's disease.
    Lawrence AD; Hodges JR; Rosser AE; Kershaw A; ffrench-Constant C; Rubinsztein DC; Robbins TW; Sahakian BJ
    Brain; 1998 Jul; 121 ( Pt 7)():1329-41. PubMed ID: 9679784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers.
    Hahn-Barma V; Deweer B; Dürr A; Dodé C; Feingold J; Pillon B; Agid Y; Brice A; Dubois B
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):172-7. PubMed ID: 9489526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Spanish version of the Addenbrooke's Cognitive Examination - Revised (ACE-R) in subcortical ischemic vascular dementia.
    Raimondi C; Gleichgerrcht E; Richly P; Torralva T; Roca M; Camino J; Manes F
    J Neurol Sci; 2012 Nov; 322(1-2):228-31. PubMed ID: 22959102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
    Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
    J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset of Huntington's disease: can it be purely cognitive?
    Paulsen JS; Long JD
    Mov Disord; 2014 Sep; 29(11):1342-50. PubMed ID: 25142616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and autonomic dysfunction in presymptomatic and early Huntington's disease.
    Kobal J; Melik Z; Cankar K; Strucl M
    J Neurol; 2014 Jun; 261(6):1119-25. PubMed ID: 24691902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease.
    Zappacosta B; Monza D; Meoni C; Austoni L; Soliveri P; Gellera C; Alberti R; Mantero M; Penati G; Caraceni T; Girotti F
    Arch Neurol; 1996 Jun; 53(6):493-7. PubMed ID: 8660149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rating scales for cognition in Huntington's disease: Critique and recommendations.
    Mestre TA; Bachoud-Lévi AC; Marinus J; Stout JC; Paulsen JS; Como P; Duff K; Sampaio C; Goetz CG; Cubo E; Stebbins GT; Martinez-Martin P;
    Mov Disord; 2018 Feb; 33(2):187-195. PubMed ID: 29278291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing impairment of executive function and psychomotor speed in premanifest and manifest Huntington's disease gene-expansion carriers.
    Unmack Larsen I; Vinther-Jensen T; Gade A; Nielsen JE; Vogel A
    J Int Neuropsychol Soc; 2015 Mar; 21(3):193-202. PubMed ID: 25850430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3.
    Stout JC; Queller S; Baker KN; Cowlishaw S; Sampaio C; Fitzer-Attas C; Borowsky B;
    Mov Disord; 2014 Sep; 29(10):1281-8. PubMed ID: 25209258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Addenbrooke's Cognitive Examination Revised (ACE-R) and its sub-scores: normative values in an Italian population sample.
    Siciliano M; Raimo S; Tufano D; Basile G; Grossi D; Santangelo F; Trojano L; Santangelo G
    Neurol Sci; 2016 Mar; 37(3):385-92. PubMed ID: 26563847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease.
    Videnovic A; Bernard B; Fan W; Jaglin J; Leurgans S; Shannon KM
    Mov Disord; 2010 Feb; 25(3):401-4. PubMed ID: 20108371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing cognitive function in patients with Huntington's disease from China: A cross-sectional clinical study.
    Cheng YF; Liu KC; Yang TM; Xiao Y; Jiang QR; Huang JX; Zhang S; Wei QQ; Ou RW; Li CY; Gu XJ; Burgunder JM; Shang HF
    Brain Behav; 2023 Nov; 13(11):e3258. PubMed ID: 37849450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the association between apathy and deficits of social cognition and executive functions in Huntington's disease.
    Hendel RK; Hellem MNN; Hjermind LE; Nielsen JE; Vogel A
    J Int Neuropsychol Soc; 2023 May; 29(4):369-376. PubMed ID: 36189712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of the Montreal Cognitive Assessment (MoCA) in Huntington's disease.
    Gluhm S; Goldstein J; Brown D; Van Liew C; Gilbert PE; Corey-Bloom J
    Mov Disord; 2013 Oct; 28(12):1744-7. PubMed ID: 23798501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairments of social cognition significantly predict the progression of functional decline in Huntington's disease: A 6-year follow-up study.
    Hendel RK; Hellem MNN; Larsen IU; Vinther-Jensen T; Hjermind LE; Nielsen JE; Vogel A
    Appl Neuropsychol Adult; 2024; 31(5):777-786. PubMed ID: 35549503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Real-life' hippocampal-dependent spatial memory impairments in Huntington's disease.
    Glikmann-Johnston Y; Carmichael AM; Mercieca EC; Stout JC
    Cortex; 2019 Oct; 119():46-60. PubMed ID: 31071556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural involvement of the cingulate cortex in premanifest and early Huntington's disease.
    Hobbs NZ; Pedrick AV; Say MJ; Frost C; Dar Santos R; Coleman A; Sturrock A; Craufurd D; Stout JC; Leavitt BR; Barnes J; Tabrizi SJ; Scahill RI
    Mov Disord; 2011 Aug; 26(9):1684-90. PubMed ID: 21557312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of two brief screening measures of cognitive impairment in Huntington's disease.
    Mickes L; Jacobson M; Peavy G; Wixted JT; Lessig S; Goldstein JL; Corey-Bloom J
    Mov Disord; 2010 Oct; 25(13):2229-33. PubMed ID: 20721924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.